Crural mesh reinforcement during large hiatal hernia repair has been advocated to defend against early recurrences. However, the optimal mesh material and configuration remain in question. This study presents the rationale and surgical technique for crural repair augmentation using Phasix™ ST Mesh. We present a case of a giant hiatal hernia and outline the rationale and surgical technique for using Phasix™ ST Mesh in the repair. A 72-year-old man presented with a giant type IV hiatal hernia. A massive mediastinal protrusion of intra-abdominal fat and viscera, and an associated crucial cardiorespiratory compromise were noted. A preoperative CT scan revealed a widened hiatus measuring 9.2 × 7.6 cm. The patient underwent laparoscopic hiatal hernia repair and Nissen fundoplication. During the procedure, following visceral reduction and hernia sac dissection and excision, a widened round hiatus and significantly thinned crura were found. To reinforce the primary crural suturing, two strips of Phasix™ ST Mesh, each measuring 1.5 × 4 cm, were used, and a U-shaped mesh was placed onlay to augment the repair. The procedure lasted 214 minutes, and the patient was discharged on the 3rd postoperative day without complications. The application of Phasix™ ST Mesh in the repair of giant hiatal hernias offers the dual benefits of reconstructing the original anatomy and reinforcing the hiatus, while avoiding the implantation of permanent foreign material around the esophagus.
29 May 2021 in Medicine: Case Reports and Study Protocols
Introduction: Struma Ovarii is one type of mature teratoma in which thyroid tissue represents more than 50% of the ovarian tumor. Diagnosis is very difficult due to lack of typical symptoms. In majority of these patients, diagnosis is incidental. Patient concerns: A 65- year-old female presented to our hospital with complaints of uterine bleeding and abdominal pain. Diagnosis: Ultrasonography showed no lesions in the uterus and left ovary, while the right ovary was enlarged, comprising a dense mass of 4 cm in diameter. Computed tomography scan revealed a mass, with fatty density and absence of fluid in the Douglas space. The lymph nodes in the posterior peritoneal space showed no enlargement. Additional Magnetic Resonance Imaging confirmed the presence of the mass with clear margins, high T1 signal and T2 sequence indicating dermal cysts. Blood tumor markers were normal. However, beta-human chorionic gonadotropin levels were slightly high. Interventions: Total hysterectomy was performed along with bilateral salpingo-oophorectomy. Outcomes: The biopsy of the mass revealed features of papillary thyroid carcinoma. The lesion was found to be benign, and the patient showed no recurrence so far. Conclusion: Struma Ovarii is a rare condition, found in only 1% of all ovarian tumors; it is benign in 95% of the cases. The clinical presentation can vary in terms of symptoms and signs. Ultrasonography can reveal the differences between a benign struma ovarii and a malignant one. Complete hysterectomy and bilateral salpingo-oophorectomy are the treatment of choice. Specific guidelines for pre- and postoperative management of the patients are yet to be elucidated.
The application of bioabsorbable PhasixST™ mesh in the laparoscopic repair of large hiatal hernias has emerged as a promising strategy to address the limitations associated with permanent synthetic meshes, particularly the risk of mesh-related complications and long-term morbidity. Recent studies have demonstrated that PhasixST™ mesh, composed of poly-4-hydroxybutyrate (P4HB), is slowly absorbed over 12 to 18 months, providing a scaffold that supports native tissue integration and healing during the critical postoperative period. This gradual absorption profile may confer an advantage over more rapidly degrading bioabsorbable meshes, as it allows for more robust tissue ingrowth and potentially enhances the durability of hiatal reinforcement. The association between P4HB mesh use and low recurrence rates has been highlighted, with an average of 2.82 hernia recurrences per 100 patients within one year, and no mesh-related complications in the current literature. The surgical technique for PhasixST™ mesh placement involves meticulous crural reinforcement, with careful attention to mesh orientation and fixation to minimize the risk of migration or erosion. The primary objective is to restore the anatomical integrity of the hiatus, reduce the size of the defect, and prevent recurrence, while minimizing perioperative morbidity.
Intracorporeal anastomosis (IA) has gained increasing acceptance in minimally invasive colorectal surgery, primarily owing to its demonstrated association with improved perioperative outcomes compared with extracorporeal techniques. Nevertheless, the specific role of intracorporeal handsewn anastomosis remains insufficiently explored within the context of laparoscopic colorectal procedures. The present study describes a standardized technique for performing a side-to-side isoperistaltic handsewn intracorporeal ileocolic anastomosis following laparoscopic right colectomy and evaluates its safety and feasibility through a review of the relevant literature and institutional experience. The procedure is executed employing a medial-to-lateral dissection approach, and a single-layer isoperistaltic handsewn anastomosis is constructed entirely intracorporeally. Over a three-year period, 68 laparoscopic right colectomies were completed using this technique, predominantly for malignant disease, all performed by a single surgeon. Notably, no anastomotic leaks or anastomosis-related complications, including bleeding, stenosis, or hematoma formation, were observed. Available evidence supports the advantages of intracorporeal anastomosis, including reduced surgical trauma, lower incidence of wound-related complications, faster recovery of bowel function, and comparable oncological outcomes. Furthermore, emerging data from robotic-assisted colorectal surgery suggest potential benefits of handsewn techniques with respect to hemostasis and anastomotic quality. In conclusion, intracorporeal handsewn ileocolic anastomosis following laparoscopic right colectomy appears to represent a safe and reproducible technique when performed by experienced surgeons, thereby warranting further prospective, comparative and multicenter studies to delineate its broader applicability and long-term outcomes.
Background: Artificial intelligence (AI) and large language models (LLMs) may make surgical information easier to access and understand. However, these tools cannot replace the clinician’s role in shared decision-making or the requirements for valid informed consent. Methods: This narrative review follows the surgical patient pathway from diagnosis and explanation to option comparison, shared decision-making, and informed consent. It examines conventional digital tools, LLM-assisted communication, personalized prediction, direct consent studies, patient and professional perspectives and legal, ethical, and governance issues. A formal meta-analysis and study-level risk-of-bias assessment were not performed. Results: AI may support several stages of surgical care. Diagnostic and predictive systems can assist clinicians. LLMs can help explain approved information, prepare patients for consultation, and improve consent materials. Conventional interactive tools have the strongest evidence for better comprehension. Evidence for LLM-assisted consent is still based mainly on simulations and document analyses. Patient-facing use requires source control, privacy protection, and visible clinical oversight. AI cannot establish capacity, voluntariness, or final authorization. We propose a five-level framework in which safeguards increase with clinical influence. Conclusions: AI may support the patient’s path from diagnosis to an informed surgical choice when it uses approved information, serves a defined task, and remains under clinical oversight. Current evidence does not support autonomous AI-mediated consent or AI-directed treatment choice. The aim should be a better-informed, preference-sensitive decision, not an automated signature.